3D tumor models: History, advances and future perspectives

Future Oncology

Volumn 10, Issue 7, 2014, Pages 1311-1327

  Benien, Parul ^a   Swami, Archana ^b  

^a MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

3D co culture; angiogenesis; cancer; hypoxia; invasion; microenvironment; microfluidics; spheroids; stem cells; tumors

Indexed keywords

ANTINEOPLASTIC AGENT; MOLECULAR SCAFFOLD;

APOPTOSIS; BIOREACTOR; CANCER CHEMOTHERAPY; CANCER RESEARCH; CANCER RESISTANCE; EMBEDDING; EX VIVO STUDY; EXPLANT; FUTUROLOGY; HANGING DROP CULTURE; HIGH THROUGHPUT SCREENING; HISTORY OF MEDICINE; HOLLOW FIBER BIOREACTOR; HOLLOW FIBER REACTOR; HUMAN; HYPOXIA; IN VIVO STUDY; MICROCARRIER CULTURE; MICROFLUIDICS; MICROTECHNOLOGY; MICROWELL PLATE; MULTICELLULAR SPHEROID; NANOTECHNOLOGY; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SPHEROID CELL; STROMA CELL; TISSUE CULTURE TECHNIQUE; TISSUE ENGINEERING; TUMOR CELL CULTURE; TUMOR MICROENVIRONMENT; TUMOR MODEL; ANIMAL; BIOLOGICAL MODEL; CELL ADHESION; DIAGNOSTIC IMAGING; NEOPLASMS; PATHOLOGY; PHYSIOLOGY; PROCEDURES;

ANIMALS; CELL ADHESION; DIAGNOSTIC IMAGING; HUMANS; MICROFLUIDICS; MODELS, BIOLOGICAL; NEOPLASMS; TISSUE ENGINEERING; TUMOR MICROENVIRONMENT;

EID: 84903143269     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.13.274     Document Type: Review

References (155)

1. Leighton J. A sponge matrix method for tissue culture; formation of organized aggregates of cells in vitro. J. Natl Cancer Inst. 12(3), 545-561 (1951).
2. Carrel A. On the permanent life of tissues outside of the organism. J. Exp. Med. 15(5), 516-528 (1912).
3. Hoffman RM. To do tissue culture in two or three dimension? That is the question. Stem Cells 11, 105-111 (1993).
4. Holtfreter J. A study of the mechanics of gastrulation. J. Exp. Zool. 95(2), 171-212 (1944).
5. Moscona A, Moscona H. The dissociation and aggregation of cells from organ rudiments of the early chick embryo. J. Anat. 86(3), 287-301 (1952).
6. Sutherland RM, McCredie JA, Inch WR. Growth of multicell spheroids in tissue culture as a model of nodular carcinomas. J. Natl Cancer Inst. 46 (1), 113-120 (1971).
7. Sherwin RP, Richters A, Yellin AE, Donovan AJ. Histoculture of human breast cancers. J. Surg. Oncol. 13(1), 9-20 (1980).
8. Hirschhaeuser F, Menne H, Dittfeld C, West J, Mueller-Klieser W, Kunz-Schughart LA. Multicellular tumor spheroids: an underestimated tool is catching up again. J. Biotechnol. 148(1), 3-15 (2010).
9. Vescio RA, Redfern CH, Nelson TJ, Ugoretz S, Stern PH, Hoffman RM. In vivo-like drug responses of human tumors growing in three-dimensional gel-supported primary culture. Proc. Natl Acad. Sci. USA 84 (14), 5029-5033 (1987).
10. Freeman AE, Hoffman RM. In vivo-like growth of human tumors in vitro. Proc. Natl Acad. Sci. USA 83(8), 2694-2698 (1986).
11. Hoffman RM. Histocultures and their use. In: Enclyclopedia of Life Science, John Wiley Sons, Ltd., Chichester, UK (2010).
12. Furukawa T, Kubota T, Hoffman RM. Clinical applications of the histoculture drug response assay. Clin. Cancer Res. 1(3), 305-311 (1995).
13. Singh B, Li R, Xu L et al. Prediction of survival in patients with head and neck cancer using the histoculture drug response assay. Head Neck 24(5), 437-442 (2002).
14. Pampaloni F, Reynaud EG, Stelzer E.H.K. The third dimension bridges the gap between cell culture and live tissue. Nat. Rev. Mol. Cell Biol. 8 (10), 839-845 (2007).
15. Kim JB. Three-dimensional tissue culture models in cancer biology. Semin. Cancer Biol. 15(5), 365-377 (2005).
16. Kimlin LC, Casagrande G, Virador VM. In vitro three-dimensional (3D) models in cancer research: an update. Mol. Carcinog. 52, 167-182 (2011).
17. Inman JL, Bissell MJ. Apical polarity in three-dimensional culture systems: where to now? J. Biol. 9 (1), 2 (2010).
18. Grun B, Benjamin E, Sinclair J et al. Three-dimensional in vitro cell biology models of ovarian and endometrial cancer. Cell Prolif. 42(2), 219-228 (2009).
19. Nagelkerke A, Bussink J, Sweep FCGJ, Span PN. Generation of multicellular tumor spheroids of breast cancer cells: how to go three-dimensional. Anal. Biochem. 437(1), 17-19 (2013).
20. Elliott N T, Yuan F. A review of three-dimensional in vitro tissue models for drug discovery and transport studies. J. Pharm. Sci. 100(1), 59-74 (2011).
21. Lin R-Z, Lin R-Z, Chang H-Y. Recent advances in three-dimensional multicellular spheroid culture for biomedical research. Biotechnol. J. 3(9-10), 1172-1184 (2008).
22. Kunz-Schughart LA, Freyer J P, Hofstaedter F, Ebner R. The use of 3-D cultures for high-throughput screening: the multicellular spheroid model. J. Biomol. Screen. 9(4), 273-285 (2004).
23. Holbeck SL. Update on NCI in vitro drug screen utilities. Eur. J. Cancer 40(6), 785-793 (2004).
24. Burdett E, Kasper FK, Mikos AG, Ludwig JA. Engineering tumors: a tissue engineering perspective in cancer biology. Tissue Eng. Part B. Rev. 16 (3), 351-359 (2010).
25. Kunz-Schughart LA, Freyer J P, Hofstaedter F, Ebner R. The use of 3-D cultures for high-throughput screening: the multicellular spheroid model. J. Biomol. Screen. 9(4), 273-285 (2004).
26. Shoemaker RH. The NCI60 human tumour cell line anticancer drug screen. Nat. Rev. Cancer 6(10), 813-823 (2006).
27. Santini MT, Rainaldi G. Three-dimensional spheroid model in tumor biology. Pathobiology 67(3), 148-157 (1999).
28. Mehta G, Hsiao AY, Ingram M, Luker GD, Takayama S. Opportunities and challenges for use of tumor spheroids as models to test drug delivery and effcacy. J. Control. Release 164(2), 192-204 (2012).
29. Breslin S, O'Driscoll L. Three-dimensional cell culture: the missing link in drug discovery. Drug Discov. Today 8, 240-249 (2013).
30. Nguyen HT, Zhuang Y, Sun L et al. Src-mediated morphology transition of lung cancer cells in three-dimensional organotypic culture. Cancer Cell Int. 13(1), 16 (2013).
31. Friedrich J, Ebner R, Kunz-Schughart LA. Experimental anti-tumor therapy in 3-D: spheroids-old hat or new challenge? Int. J. Radiat. Biol. 83(11-12), 849-871 (2007).
32. O'Connor KC. Three-dimensional cultures of prostatic cells: tissue models for the development of novel anti-cancer therapies. Pharm. Res. 16(4), 486-493 (1999).
33. Patton LL, Brahim JS, Travis WD. Mandibular osteomyelitis in a patient with sickle cell anemia: report of case. J. Am. Dent. Assoc. 121(5), 602-604 (1990).
34. Clark JM, Hirtenstein MD. Optimizing culture conditions for the production of animal cells in microcarrier culture. Ann. NY Acad. Sci. 369, 33-46 (1981).
35. Skardal A, Sarker SF, Crabbé A, Nickerson CA, Prestwich GD. The generation of 3-D tissue models based on hyaluronan hydrogel-coated microcarriers within a rotating wall vessel bioreactor. Biomaterials 31(32), 8426-8435 (2010).
36. Chen AK-L, Chen X, Choo ABH, Reuveny S, Oh SKW. Critical microcarrier properties affecting the expansion of undifferentiated human embryonic stem cells. Stem Cell Res. 7 (2), 97-111 (2011).
37. Lama R, Zhang L, Naim JM, Williams J, Zhou A, Su B. Development, validation and pilot screening of an in vitro multi-cellular three-dimensional cancer spheroid assay for anti-cancer drug testing. Bioorg. Med. Chem. 21(4), 922-931 (2013).
38. Herrmann R, Fayad W, Schwarz S, Berndtsson M, Linder S. Screening for compounds that induce apoptosis of cancer cells grown as multicellular spheroids. J. Biomol. Screen. 13(1), 1-8 (2008).
39. Smalley KSM, Lioni M, Herlyn M. Life isn't fat: taking cancer biology to the next dimension. In vitro Cell. Dev. Biol. Anim. 42(8-9), 242-247 (2006).
40. Saleh F A, Genever PG. Turning round: multipotent stromal cells, a three-dimensional revolution? Cytotherapy 13(8), 903-912 (2011).
41. Pampaloni F, Stelzer EHK, Leicht S, Marcello M. Madin-Darby canine kidney cells are increased in aerobic glycolysis when cultured on fat and stiff collagen-coated surfaces rather than in physiological 3-D cultures. Proteomics 10 (19), 3394-3413 (2010).
42. Kumar HR, Zhong X, Hoelz DJ et al. Three-dimensional neuroblastoma cell culture: proteomic analysis between monolayer and multicellular tumor spheroids. Pediatr. Surg. Int. 24(11), 1229-1234 (2008).
43. Bates RC, Edwards NS, Yates JD. Spheroids and cell survival. Crit. Rev. Oncol. Hematol. 36(2-3), 61-74 (2000).
44. Bates RC, Buret A, van Helden DF, Horton MA, Burns GF. Apoptosis induced by inhibition of intercellular contact. J. Cell Biol. 125(2), 403-415 (1994).
45. Lee JM, Mhawech-Fauceglia P, Lee N et al. A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro. Lab. Invest. 93(5), 528-542 (2013).
46. Shweiki D, Neeman M, Itin A, Keshet E. Induction of vascular endothelial growth factor expression by hypoxia and by glucose defciency in multicell spheroids: implications for tumor angiogenesis. Proc. Natl Acad. Sci. USA 92(3), 768-772 (1995).
47. Brown JM, Giaccia AJ. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res. 58(7), 1408-1416 (1998).
48. Hamilton G. Multicellular spheroids as an in vitro tumor model. Cancer Lett. 131(1), 29-34 (1998).
49. Harrison L, Blackwell K. Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy? Oncologist 9(Suppl. 5), 31-40 (2004).
50. Lord EM, Harwell L, Koch CJ. Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts. Cancer Res. 53(23), 5721-5726 (1993).
51. Newsam JM, King-Smith D, Jain A et al. Screening soft materials for their effect on skin barrier function by high throughput experimentation. J. Mater. Chem. 15(30), 3061 (2005).
52. Gross MW, Karbach U, Groebe K, Franko AJ, Mueller-Klieser W. Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density in multicellular spheroids. Int. J. Cancer 61(4), 567-573 (1995).
53. Durand RE. The infuence of microenvironmental factors during cancer therapy. In Vivo 8(5), 691-702 (1994).
54. Mueller-Klieser W. Three-dimensional cell cultures: from molecular mechanisms to clinical applications. Am. J. Physiol. 273(4 Pt 1), C1109-C1123 (1997).
55. 2 measurements in cell spheroids cultured with different techniques. Br. J. Cancer 56(3), 325-327 (1987).
56. Carlsson J, Acker H. Relations between pH, oxygen partial pressure and growth in cultured cell spheroids. Int. J. Cancer 42(5), 715-720 (1988).
57. Kunz-Schughart LA. Multicellular tumor spheroids: intermediates between monolayer culture and in vivo tumor. Cell Biol. Int. 23(3), 157-161 (1999).
58. Mueller-Klieser W. Tumor biology and experimental therapeutics. Crit. Rev. Oncol. Hematol. 36(2-3), 123-139 (2000).
59. Miller BE, Miller FR, Heppner GH. Assessing tumor drug sensitivity by a new in vitro assay which preserves tumor heterogeneity and subpopulation interactions. J. Cell. Physiol. Suppl. 3, 105-116 (1984).
60. Hoffman RM. Three-dimensional histoculture: origins and applications in cancer research. Cancer Cells 3(3), 86-92 (1991).
61. Hoffman RM. The three-dimensional question: can clinically relevant tumor drug resistance be measured in vitro? Cancer Metastasis Rev. 13(2), 169-173 (1994).
62. McMillin DW, Negri JM, Mitsiades CS. The role of tumour-stromal interactions in modifying drug response: challenges and opportunities. Nat. Rev. Drug Discov. 12(3), 217-228 (2013).
63. Hida K, Akiyama K, Ohga N, Maishi N, Hida Y. Tumour endothelial cells acquire drug resistance in a tumour microenvironment. J. Biochem. 153 (3), 243-249 (2013).
64. Westhoff M-A, Fulda S. Adhesion-mediated apoptosis resistance in cancer. Drug Resist. Updat. 12(4-5), 127-136 (2009).
65. Kawai K, Kamatani N, Georges E, Ling V. Identifcation of a membrane glycoprotein overexpressed in murine lymphoma sublines resistant to cis-diamminedichloro-platinum(II). J. Biol. Chem. 265(22), 13137-13142 (1990).
66. St Croix B, Kerbel RS. Cell adhesion and drug resistance in cancer. Curr. Opin. Oncol. 9(6), 549-556 (1997).
67. Eke I, Cordes N. Radiobiology goes 3D: how ECM and cell morphology impact on cell survival after irradiation. Radiother. Oncol. 99(3), 271-278 (2011).
68. Roulston A, Muller WJ, Shore GC. BIM, PUMA, and the achilles' heel of oncogene addiction. Sci. Signal. 6(268), pe12 (2013).
69. Härmä V, Virtanen J, Mäkelä R et al. A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses. PLoS ONE 5(5), e10431 (2010).
70. Lopez JI, Kang I, You W-K, McDonald DM, Weaver VM. In situ force mapping of mammary gland transformation. Integr. Biol. (Camb). 3 (9), 910-921 (2011).
71. Levental KR, Yu H, Kass L et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139(5), 891-906 (2009).
72. Yeung T, Georges PC, Flanagan LA et al. Effects of substrate stiffness on cell morphology, cytoskeletal structure, and adhesion. Cell Motil. Cytoskeleton 60(1), 24-34 (2005).
73. Hu M, Polyak K. Microenvironmental regulation of cancer development. Curr. Opin. Genet. Dev. 18(1), 27-34 (2008).
74. Luca AC, Mersch S, Deenen R et al. Impact of the 3D microenvironment on phenotype, gene expression, and EGFR inhibition of colorectal cancer cell lines. PLoS ONE 8(3), e59689 (2013).
75. Jacks T, Weinberg RA. Taking the study of cancer cell survival to a new dimension. Cell 111(7), 923-925 (2002).
76. Folkman J, Greenspan HP. Infuence of geometry on control of cell growth. Biochim. Biophys. Acta 417(3-4), 211-236 (1975).
77. Duffy MJ, McGowan PM, Gallagher WM. Cancer invasion and metastasis: changing views. J. Pathol. 214(3), 283-293 (2008).
78. Green SK, Frankel A, Kerbel RS. Adhesion-dependent multicellular drug resistance. Anticancer. Drug Des. 14(2), 153-168 (1999).
79. Monier-Gavelle F, Duband JL. Cross talk between adhesion molecules: control of N-cadherin activity by intracellular signals elicited by beta1 and beta3 integrins in migrating neural crest cells. J. Cell Biol. 137(7), 1663-1681 (1997).
80. Matsumura Y. Cancer stromal targeting (CAST) therapy. Adv. Drug Deliv. Rev. 64(8), 710-719 (2012).
81. Khalil AA, Friedl P. Determinants of leader cells in collective cell migration. Integr. Biol. (Camb.) 2(11-12), 568-574 (2010).
82. Mueller MM, Fusenig NE. Friends or foes-bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer 4(11), 839-849 (2004).
83. Hiscox S, Barrett-Lee P, Nicholson RI. Therapeutic targeting of tumor-stroma interactions. Expert Opin. Ther. Targets 15 (5), 609-621 (2011).
84. NCI. Clinical Trials. www.cancer.gov/clinicaltrials/search/results?p rotocolsearchid=11740822
85. Bissell MJ, Radisky D. Putting tumours in context. Nat. Rev. Cancer 1(1), 46-54 (2001).
86. De Ridder L, Cornelissen M, de Ridder D. Autologous spheroid culture: a screening tool for human brain tumour invasion. Crit. Rev. Oncol. Hematol. 36(2-3), 107-122 (2000).
87. Corcoran A, De Ridder LIF, Del Duca D et al. Evolution of the brain tumour spheroid model: transcending current model limitations. Acta Neurochir. (Wien) 145(9), 819-824 (2003).
88. Yamada KM, Cukierman E. Modeling tissue morphogenesis and cancer in 3D. Cell 130(4), 601-610 (2007).
89. Sampson N, Neuwirt H, Puhr M, Klocker H, Eder IE. in vitro model systems to study androgen receptor signaling in prostate cancer. Endocr. Relat. Cancer 20(2), R49-R64 (2013).
90. Kunz-Schughart LA, Kreutz M, Knuechel R. Multicellular spheroids: a three-dimensional in vitro culture system to study tumour biolog y. Int. J. Exp. Pathol. 79(1), 1-23 (1998).
91. Feder-Mengus C, Ghosh S, Reschner A, Martin I, Spagnoli GC. New dimensions in tumor immunology: what does 3D culture reveal? Trends Mol. Med. 14(8), 333-340 (2008).
92. Gottfried E, Kunz-Schughart LA, Andreesen R, Kreutz M. Brave little world: spheroids as an in vitro model to study tumor-immune-cell interactions. Cell Cycle 5(7), 691-695 (2006).
93. Grill J, Van Beusechem V W, Van Der Valk P et al. Combined targeting of adenoviruses to integrins and epidermal growth factor receptors increases gene transfer into primary glioma cells and spheroids. Clin. Cancer Res. 7(3), 641-650 (2001).
94. Muthana M, Scott SD, Farrow N et al. A novel magnetic approach to enhance the effcacy of cell-based gene therapies. Gene Ther. 15 (12), 902-910 (2008).
95. Rohde D, Brkovic D, Hönig d'Orville I. All-trans retinoic acid and interferon-alpha for treatment of human renal cell carcinoma multicellular tumor spheroids. Urol. Int. 73(1), 47-53 (2004).
96. Mueller-Klieser W. Multicellular spheroids. A review on cellular aggregates in cancer research. J. Cancer Res. Clin. Oncol. 113(2), 101-122 (1987).
97. Verbridge SS, Chakrabarti A, Delnero P et al. Physicochemical regulation of endothelial sprouting in a 3D microfuidic angiogenesis model. J. Biomed. Mater. Res. A (101, 2948-2956 (2013).
98. Hutmacher DW, Horch RE, Loessner D et al. Translating tissue engineering technology platforms into cancer research. J. Cell. Mol. Med. 13(8a), 1417-1427 (2009).
99. Mollica F, Jain RK, Netti PA. A model for temporal heterogeneities of tumor blood fow. Microvasc. Res. 65(1), 56-60 (2003).
100. Folkman J. Fundamental concepts of the angiogenic process. Curr. Mol. Med. 3(7), 643-651 (2003).
101. Correa de Sampaio P, Auslaender D, Krubasik D et al. A heterogeneous in vitro three dimensional model of tumour-stroma interactions regulating sprouting angiogenesis. PLoS ONE 7(2), e30753 (2012).
102. Haspel HC, Scicli GM, McMahon G, Scicli AG. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis. Microvasc. Res. 63(3), 304-315 (2002).
103. Zeitlin BD, Dong Z, Nör JE. RAIN-Droplet: a novel 3D in vitro angiogenesis model. Lab. Invest. 92(7), 988-998 (2012).
104. Vinci M, Gowan S, Boxall F et al. Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biol. 10, 29 (2012).
105. Ivascu A, Kubbies M. Rapid generation of single-tumor spheroids for high-throughput cell function and toxicity analysis. J. Biomol. Screen. 11(8), 922-932 (2006).
106. Truong HH, de Sonneville J, Ghotra VPS et al. Automated microinjection of cell-polymer suspensions in 3D ECM scaffolds for high-throughput quantitative cancer invasion screens. Biomaterials 33(1), 181-188 (2012).
107. Zhou Y, Arai T, Horiguchi Y, Ino K, Matsue T, Shiku H. Multi-parameter analyses of three-dimensionally cultured tumor spheroids based on respiratory activity and comprehensive gene-expression profles. Anal. Biochem. 439, 187-193 (2013).
108. Krausz E, de Hoogt R, Gustin E et al. Translation of a tumor microenvironment mimicking 3D tumor growth co-culture assay platform to high-content screening. J. Biomol. Screen. 18(1), 54-66 (2013).
109. Okuyama T, Yamazoe H, Mochizuki N, Khademhosseini A, Suzuki H, Fukuda J. Preparation of arrays of cell spheroids and spheroid-monolayer cocultures within a microfuidic device. J. Biosci. Bioeng. 110(5), 572-576 (2010).
110. Park CC, Georgescu W, Polyzos A et al. Rapid and automated multidimensional fuorescence microscopy profling of 3D human breast cultures. Integr. Biol. (Camb.) 5(4), 681-691 (2013).
111. Knowles DW, Sudar D, Bator-Kelly C, Bissell MJ, Lelièvre SA. Automated local bright feature image analysis of nuclear protein distribution identifes changes in tissue phenotype. Proc. Natl Acad. Sci. USA 103(12), 4445-4450 (2006).
112. Frieboes HB, Zheng X, Sun C-H, Tromberg B, Gatenby R, Cristini V. An integrated computational/experimental model of tumor invasion. Cancer Res. 66(3), 1597-1604 (2006).
113. Watson JM, Marion SL, Rice PF et al Two-photon excited fuorescence imaging of endogenous contrast in a mouse model of ovarian cancer. Lasers Surg. Med. 45(3), 155-166 (2013).
114. Madden KS, Zettel ML, Majewska AK, Brown EB. Brain tumor imaging: live imaging of glioma by two-photon microscopy. Cold Spring Harb. Protoc. 2013(3), pii (2013).
115. Jain RK. Delivery of molecular and cellular medicine to solid tumors. Adv. Drug Deliv. Rev. 46(1-3), 149-168 (2001).
116. Verveer PJ, Swoger J, Pampaloni F, Greger K, Marcello M, Stelzer E.H.K. High-resolution three-dimensional imaging of large specimens with light sheet-based microscopy. Nat. Methods 4(4), 311-313 (2007).
117. Lorenzo C, Frongia C, Jorand R et al. Live cell division dynamics monitoring in 3D large spheroid tumor models using light sheet microscopy. Cell Div. 6, 22 (2011).
118. Pampaloni F, Ansari N, Stelzer E.H.K. High-resolution deep imaging of live cellular spheroids with light-sheet-based fuorescence microscopy. Cell Tissue Res. 352(1), 161-177 (2013).
119. Ho WY, Yeap SK, Ho CL, Rahim RA, Alitheen NB. Development of multicellular tumor spheroid (MCTS) culture from breast cancer cell and a high throughput screening method using the MTT assay. PLoS ONE 7(9), e44640 (2012).
120. Freyer JP, Wilder ME, Jett JH. Viable sorting of intact multicellular spheroids by fow cytometry. Cytometry 8(4), 427-436 (1987).
121. Sumitomo Bakelite. www.sumibe.co.jp/english
122. NOF Europe. www.nofeurope.com
123. Happy Cell. www.happy-cell.com
124. 3D Biomatrix. http://3dbiomatrix.com
125. InSphero. www.insphero.com
126. Wheaton. www.wheatonsci.com
127. Corning. www.corning.com
128. Synthecon. www.synthecon.com
129. BD Biosciences. www.bdbiosciences.com
130. amsbio. www.amsbio.com
131. Sigma-Aldrich. www.sigmaaldrich.com
132. Millipore. www.millipore.com
133. Invitrogen. www.invitrogen.com
134. GE Healthcare. www.gehealthcare.com/eueu
135. Solohill. www.solohill.com
136. Global Cell Solutions. www.globalcellsolutions.com
137. BellBrook Labs. www.bellbrooklabs.com
138. CellASIC. www.cellasic.com
139. Herman AB, Savage VM, West GB. A quantitative theory of solid tumor growth, metabolic rate and vascularization. PLoS ONE 6(9), e22973 (2011).
140. Tabatabai M, Williams DK, Bursac Z. Hyperbolastic growth models: theory and application. Theor. Biol. Med. Model. 2, 14 (2005).
141. Wallace DI, Guo X. Properties of tumor spheroid growth exhibited by simple mathematical models. Front. Oncol. 3, 51 (2013).
142. Frieboes HB, Smith BR, Chuang Y-L et al. An integrated computational/experimental model of lymphoma growth. PLoS Comput. Biol. 9(3), e1003008 (2013).
143. Kim E, Stamatelos S, Cebulla J, Bhujwalla ZM, Popel AS, Pathak AP. Multiscale imaging and computational modeling of blood fow in the tumor vasculature. Ann. Biomed. Eng. 40(11), 2425-2441 (2012).
144. Stein AM, Demuth T, Mobley D, Berens M, Sander LM. A mathematical model of glioblastoma tumor spheroid invasion in a three-dimensional in vitro experiment. Biophys. J. 92(1), 356-365 (2007).
145. Van de Ven AL, Wu M, Lowengrub J et al. Integrated intravital microscopy and mathematical modeling to optimize nanotherapeutics delivery to tumors. AIP Adv. 2(1), 11208 (2012).
146. Frieboes HB, Wu M, Lowengrub J, Decuzzi P, Cristini V. A computational model for predicting nanoparticle accumulation in tumor vasculature. PLoS ONE 8(2), e56876 (2013).
147. Loessner D, Flegg JA, Byrne HM, Clements JA, Hutmacher DW. Growth of confned cancer spheroids: a combined experimental and mathematical modelling approach. Integr. Biol. (Camb). 5(3), 597-605 (2013).
148. Barrantes-Freer A, Kim E, Bielanska J et al. Human glioma-initiating cells show a distinct immature phenotype resembling but not identical to NG2 glia. J. Neuropathol. Exp. Neurol. 72(4), 307-324 (2013).
149. Sato T, van Es JH, Snippert HJ et al. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 469(7330), 415-418 (2011).
150. Pampaloni F, Reynaud EG, Stelzer E.H.K. The third dimension bridges the gap between cell culture and live tissue. Nat. Rev. Mol. Cell Biol. 8 (10), 839-845 (2007).
151. Brouquet A, Taleb P, Lot A-S et al. A model of primary culture of colorectal cancer and liver metastasis to predict chemosensitivity. J. Surg. Res. 166(2), 247-254 (2011).
152. Fischbach C, Chen R, Matsumoto T et al. Engineering tumors with 3D scaffolds. Nat. Methods 4(10), 855-860 (2007).
153. Zhang X-Q, Xu X, Bertrand N, Pridgen E, Swami A, Farokhzad OC. Interactions of nanomaterials and biological systems: implications to personalized nanomedicine. Adv. Drug Deliv. Rev. 64(13), 1363-1384 (2012).
154. Phung YT, Barbone D, Broaddus VC, Ho M. Rapid generation of in vitro multicellular spheroids for the study of monoclonal antibody therapy. J. Cancer 2, 507-514 (2011).
155. Chang TT, Hughes-Fulford M. Monolayer and spheroid culture of human liver hepatocellular carcinoma cell line cells demonstrate distinct global gene expression patterns and functional phenotypes. Tissue Eng. Part A 15(3), 559-567 (2009).